GeneDx Hldgs Analyst Ratings
TD Cowen Adjusts GeneDx Holdings' Price Target to $24 From $14, Keeps Buy Rating
GeneDx Hldgs Analyst Ratings
BTIG Maintains Buy on GeneDx Hldgs, Raises Price Target to $19
GeneDx Holdings (WGS) Receives a Buy From BTIG
GeneDx Hldgs Analyst Ratings
GeneDx Hldgs Analyst Ratings
GeneDx Holdings (WGS) Gets a Buy From TD Cowen
Analysts Offer Insights on Healthcare Companies: GeneDx Holdings (WGS) and Glaukos (GKOS)
Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), GeneDx Holdings (WGS) and Halozyme (HALO)
GeneDx Holdings (WGS) Gets a Buy From BTIG
BTIG Sticks to Its Buy Rating for GeneDx Holdings (WGS)
Goldman Sachs Maintains Neutral on GeneDx Hldgs, Lowers Price Target to $6
GeneDx Hldgs Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), GeneDx Holdings (WGS) and Protalix (PLX)
Goldman Sachs Maintains Neutral on GeneDx Hldgs, Lowers Price Target to $7
GeneDx Hldgs Analyst Ratings
GeneDx Holdings (WGS) Receives a Buy From BTIG
GeneDx Hldgs Analyst Ratings
Goldman Sachs Adjusts Price Target on GeneDx to $8 From $9, Maintains Neutral Rating